ORIC Pharmaceuticals (ORIC) PT Raised to $15 at Oppenheimer
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Price: $13.65 -1.59%
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Oppenheimer analyst Matthew Biegler raised the price target on ORIC Pharmaceuticals (NASDAQ: ORIC) to $15.00 (from $12.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Brother Industries Ltd (6448:JP) to Neutral
- GMO Payment Gateway Inc (3769:JP) PT Lowered to JPY13,200 at Nomura/Instinet
- Mabuchi Motor Co Ltd. (6592:JP) (MBUMY) PT Raised to JPY1,730 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
